Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11066)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 7, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i5/377.htm |
| Number | Citing Articles |
| 1 |
Isidora Vujčić. Outcomes of COVID-19 among patients with liver disease. World Journal of Gastroenterology 2023; 29(5): 815-824 doi: 10.3748/wjg.v29.i5.815
|
| 2 |
Zulal Ozkurt, Esra Çınar Tanrıverdi. COVID-19: Gastrointestinal manifestations, liver injury and recommendations. World Journal of Clinical Cases 2022; 10(4): 1140-1163 doi: 10.12998/wjcc.v10.i4.1140
|
| 3 |
Dafan Chen, Min Ning, Yun Feng, Jun Liu. The early stage of COVID-19 pandemic: Gastrointestinal manifestations and liver injury in COVID-19 patients in Wuhan, China. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.997000
|
| 4 |
Alexandre Balaphas, Kyriaki Gkoufa, Nicola Colucci, Konstantinos-Cédric Perdikis, Christophe Gaudet-Blavignac, Zoltan Pataky, Sebastian Carballo, Frédéric Ris, Jérôme Stirnemann, Christian Lovis, Nicolas Goossens, Christian Toso. Abdominal pain patterns during COVID-19: an observational study. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18753-0
|
| 5 |
Yue Shi, Mina Wang, Liqun Wu, Xuexin Li, Zehuan Liao. COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups. Liver Research 2023; 7(3): 207 doi: 10.1016/j.livres.2023.07.001
|
| 6 |
Amal Oweid Almutairi, Mahmoud Zaki El-Readi, Mohammad Althubiti, Yosra Zakariyya Alhindi, Nahla Ayoub, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Safaa Yehia Eid. Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study. Tropical Medicine and Infectious Disease 2023; 8(2): 129 doi: 10.3390/tropicalmed8020129
|
| 7 |
Liliana Łykowska-Szuber, Karolina Wołodźko, Anna Maria Rychter, Aleksandra Szymczak-Tomczak, Iwona Krela-Kaźmierczak, Agnieszka Dobrowolska. Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)—A Narrative Review. Journal of Clinical Medicine 2021; 10(21): 5048 doi: 10.3390/jcm10215048
|
| 8 |
Bircan Kayaaslan, Rahmet Guner. COVID-19 and the liver: A brief and core review. World Journal of Hepatology 2021; 13(12): 2013-2023 doi: 10.4254/wjh.v13.i12.2013
|
| 9 |
Fouzia Shoeb, Farzana Mahdi, Imran Hussain. Gender Differences Associated with Hyper-Inflammatory Conditions in COVID-19 Patients. Aging and disease 2022; : 0 doi: 10.14336/AD.2022.0830
|
| 10 |
Mohammad Mehdi Ommati, Ali Mobasheri, Reza Heidari. Drug‐induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies. Journal of Biochemical and Molecular Toxicology 2021; 35(7) doi: 10.1002/jbt.22795
|
| 11 |
Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, Kiana Moayedi, Omid Soliemanifar, Chrysovalantou Eleni Xirouchaki, Damoon Ashtary-Larky, Shadisadat Seyyedebrahimi, Shaban Alizadeh. Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-term
Symptoms of COVID-19 After Recovery: A Review. Mini-Reviews in Medicinal Chemistry 2023; 23(7): 852 doi: 10.2174/1389557523666221116154907
|
| 12 |
Wiwat Chancharoenthana, Supitcha Kamolratanakul, Asada Leelahavanichkul, Wassawon Ariyanon, Sutatip Chinpraditsuk, Rattanaporn Saelim, Somratai Vadcharavivad, Weerapong Phumratanaprapin, Polrat Wilairatana. Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort study. World Journal of Gastroenterology 2023; 29(19): 3013-3026 doi: 10.3748/wjg.v29.i19.3013
|
| 13 |
Xiaopeng Yang, Hao Zheng, Junlong Niu, Xiaoshuang Chen, Hongfei Li, Zhiyong Rao, Yongpeng Guo, Wei Zhang, Zhixiang Wang. Curcumin alleviates zearalenone-induced liver injury in mice by scavenging reactive oxygen species and inhibiting mitochondrial apoptosis pathway. Ecotoxicology and Environmental Safety 2024; 277: 116343 doi: 10.1016/j.ecoenv.2024.116343
|
| 14 |
Eleni Karlafti, Daniel Paramythiotis, Konstantina Pantazi, Vasiliki Epameinondas Georgakopoulou, Georgia Kaiafa, Petros Papalexis, Adonis A. Protopapas, Eleftheria Ztriva, Varvara Fyntanidou, Christos Savopoulos. Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection. Medicina 2022; 58(12): 1848 doi: 10.3390/medicina58121848
|
| 15 |
Marcos Roberto Tovani-Palone, Paolo Pedersini. Potential role of the microbiome in liver injury during COVID-19: Further research is needed. World Journal of Gastroenterology 2023; 29(3): 503-507 doi: 10.3748/wjg.v29.i3.503
|
| 16 |
I. N. Tikhonov, V. T. Ivashkin, M. S. Zharkova, M. V. Maevskaya, S. N. Koloteeva, A. S. Sarsenbaeva, L I. Tkachenko, O. V. Aronova, E. K. Tsvetaeva, N I. Trofimovskaya. Results of the non-interventional observational program: Influence of Novel COroNavirus on the condition of patients with liver and gastrointestinal Tract diseases and the effect of Ursodeoxycholic acid drugs and Rebamipide on the course of COVID-19 infection (CONTUR). Meditsinskiy sovet = Medical Council 2022; (21-1): 106 doi: 10.21518/2079-701X-2021-21-1-106-119
|
| 17 |
Nazanin Aghamohamadi, Faezeh Shahba, Ali Zarezadeh Mehrabadi, Hossein Khorramdelazad, Milad Karimi, Reza Falak, Reza Zolfaghari Emameh. Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1139692
|
| 18 |
Khansa Ahsan, Munir Ahmad Anwar, Nayla Munawar. Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients. World Journal of Gastroenterology 2023; 29(11): 1708-1720 doi: 10.3748/wjg.v29.i11.1708
|
| 19 |
Ming-Ke Wang, Xue-Lu Yu, Li-Yun Zhou, Hong-Mei Si, Ju-Fen Hui, Deng-Yong Hou, Wei-Peng Li, Ji-Shun Yang. COVID-19 and liver dysfunction: What nutritionists need to know. World Journal of Gastroenterology 2022; 28(15): 1526-1535 doi: 10.3748/wjg.v28.i15.1526
|
| 20 |
Mariana Helou, Janane Nasr, Nour El Osta, Elsy Jabbour, Rola Husni. Liver manifestations in COVID-19 patients: A review article. World Journal of Clinical Cases 2023; 11(10): 2189-2200 doi: 10.12998/wjcc.v11.i10.2189
|
| 21 |
Gianni TESTINO, Rinaldo PELLICANO. Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient. Minerva Gastroenterology 2021; 67(3) doi: 10.23736/S2724-5985.21.02893-X
|
| 22 |
Andrei Voiosu, Adina Roman, Ruxandra Pop, Alina Boeriu, Cristiana Popp, Sabina Zurac, Theodor Voiosu, Daniela Dobru, Bogdan Mateescu. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience. Romanian Journal of Internal Medicine 2022; 60(1): 49 doi: 10.2478/rjim-2021-0027
|
| 23 |
Abhishek Singhai, G. Sai Pavan, Smritimayee Panda. Evaluation of liver function in symptomatic COVID-19 patients. Journal of Family Medicine and Primary Care 2021; 10(9): 3252 doi: 10.4103/jfmpc.jfmpc_2527_20
|
| 24 |
Neira Crnčević, Zijah Rifatbegović, Mirsada Hukić, Sara Deumić, Emina Pramenković, Amir Selimagić, Ismet Gavrankapetanović, Monia Avdić. Atypical Viral Infections in Gastroenterology. Diseases 2022; 10(4): 87 doi: 10.3390/diseases10040087
|
| 25 |
Lokjan Singh, Anil Kumar, Maya Rai, Bibek Basnet, Nishant Rai, Pukar Khanal, Kok-Song Lai, Wan-Hee Cheng, Ahmed Morad Asaad, Shamshul Ansari. Spectrum of COVID-19 induced liver injury: A review report. World Journal of Hepatology 2024; 16(4): 517-536 doi: 10.4254/wjh.v16.i4.517
|
| 26 |
Ioannis G Lempesis, Eleni Karlafti, Petros Papalexis, George Fotakopoulos, Kyriakos Tarantinos, Vasileios Lekakis, Stavros P Papadakos, Evangelos Cholongitas, Vasiliki E Georgakopoulou. COVID-19 and liver injury in individuals with obesity. World Journal of Gastroenterology 2023; 29(6): 908-916 doi: 10.3748/wjg.v29.i6.908
|
| 27 |
Bianca Cerbu, Stelian Pantea, Felix Bratosin, Iulia Vidican, Mirela Turaiche, Stefan Frent, Ema Borsi, Iosif Marincu. Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic. Medicina 2021; 57(6): 597 doi: 10.3390/medicina57060597
|
| 28 |
Anisha Choudhary, Vinita Singh, Murari Bharadwaj, Archana Barik. Pregnancy With SARS-CoV-2 Infection Complicated by Preeclampsia and Acute Fatty Liver of Pregnancy. Cureus 2021; doi: 10.7759/cureus.15645
|
| 29 |
L.D. Sadretdinova, Kh.Kh. Gantseva, D.S. Vishnyakov, V.B. Golubyatnikov, D.Kh. Kalimullina, V.N. Pavlov, A.V. Tyurin. Gastrointestinal injury in COVID-19. Profilakticheskaya meditsina 2022; 25(7): 106 doi: 10.17116/profmed202225071106
|
| 30 |
Roberto Lovero, Ioannis Alexandros Charitos, Skender Topi, Francesca Castellaneta, Angela Pia Cazzolla, Marica Colella. Current Views About the Link between SARS-CoV-2 and the Liver:
Friends or Foe?. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(6): 642 doi: 10.2174/0118715303251985231009050626
|
| 31 |
Igor V. Maev, Mikhail A. Osadchuk. Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review. Terapevticheskii arkhiv 2022; 94(11): 1326 doi: 10.26442/00403660.2022.11.201934
|
| 32 |
Rania M. Sarhan, Hadeer S. Harb, Ahmed E. Abou Warda, Mounir M. Salem-Bekhit, Faiyaz Shakeel, Sami Ali Alzahrani, Yasmin M. Madney, Marian S. Boshra. Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients. Journal of Infection and Public Health 2022; 15(1): 116 doi: 10.1016/j.jiph.2021.10.024
|
| 33 |
S. V. Sokologorskiy, A. M. Ovechkin, I. V. Khapov, M. E. Politov, E. L. Bulanova. Risk Factors of Severe Disease and Methods for Clinical Outcome Prediction in Patients with COVID-19 (Review). General Reanimatology 2022; 18(1): 31 doi: 10.15360/1813-9779-2022-1-31-38
|
| 34 |
Elahe Roshanzamir, Sayed Mostafa Pourhosseni, Mohammad Bagher Sohrabi, Hamid Vahedi. Prevalence of Impaired Liver Tests in Hospitalized Patients With COVID19 and its Relationship With Length of Hospital Stay and Mortality Rate. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4007458
|
| 35 |
Lekha Saha, Soumya Vij, Kajal Rawat. Liver injury induced by COVID 19 treatment – what do we know?. World Journal of Gastroenterology 2022; 28(45): 6314-6327 doi: 10.3748/wjg.v28.i45.6314
|
| 36 |
Samar A. Antar, Nada A. Ashour, Amir O. Hamouda, Ayman M. Noreddin, Ahmed A. Al‐Karmalawy. Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management. Inflammopharmacology 2024; 32(5): 2649 doi: 10.1007/s10787-024-01535-7
|
| 37 |
Diana I. Abdulganieva, Dilyara D. Mukhametova, Nailya G. Shamsutdinova, Alsou M. Galieva. Abnormal liver function tests in patients with COVID-19. Experimental and Clinical Gastroenterology 2022; (7): 123 doi: 10.31146/1682-8658-ecg-203-7-123-130
|
| 38 |
George D Liatsos. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups. World Journal of Gastroenterology 2023; 29(16): 2397-2432 doi: 10.3748/wjg.v29.i16.2397
|
| 39 |
|
| 40 |
Yuyin Fang, Peizhen Lao, Longqian Tang, Jingyi Chen, Yuxi Chen, Lei Sun, Wenwen Tan, Xingliang Fan. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment. Cell Transplantation 2023; 32 doi: 10.1177/09636897231184611
|
| 41 |
Carmine Finelli. Gut Microbiota, NAFLD and COVID-19: A Possible Interaction. Obesities 2022; 2(2): 215 doi: 10.3390/obesities2020017
|
| 42 |
Tian LAN, Xiaolin LIANG, Xiaoyu HU, Wuping WANG, Laiyou WANG, Ling YANG, Lexun WANG, Xianglu RONG, Jiao GUO. A neglected complication of COVID-19: liver injury. Journal of Holistic Integrative Pharmacy 2021; 2(1): 11 doi: 10.1016/S2707-3688(23)00019-5
|
| 43 |
Titus Rössler, Georgy Berezhnoy, Yogesh Singh, Claire Cannet, Tony Reinsperger, Hartmut Schäfer, Manfred Spraul, Manfred Kneilling, Uta Merle, Christoph Trautwein. Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical Parameters. Metabolites 2022; 12(12): 1277 doi: 10.3390/metabo12121277
|
| 44 |
Effie Polyzogopoulou, Pinelopi Amoiridou, Theodore P Abraham, Ioannis Ventoulis. Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review. World Journal of Gastroenterology 2022; 28(47): 6662-6688 doi: 10.3748/wjg.v28.i47.6662
|
| 45 |
Mihaela Cătălina Luca, Isabela Ioana Loghin, Ioana Florina Mihai, Radu Popa, Andrei Vâţă, Carmen Manciuc. Liver Damage Associated with SARS-CoV-2 Infection—Myth or Reality?. Journal of Personalized Medicine 2023; 13(2): 349 doi: 10.3390/jpm13020349
|
| 46 |
M Vinutha, Uday Raj Sharma, Gurubasvaraja Swamy, S Rohini, Surendra Vada, Suresh Janandri, T Haribabu, Nageena Taj, SV Gayathri, SK Jyotsna, Manjunatha P Mudagal. COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review. Life Sciences 2024; 356: 123022 doi: 10.1016/j.lfs.2024.123022
|
| 47 |
必琼 张. Research Progress of COVID-19 Vaccination in Patients with Chronic Liver Diseases. Advances in Clinical Medicine 2023; 13(06): 9060 doi: 10.12677/ACM.2023.1361268
|
| 48 |
Deepak Parchwani, Amit D Sonagra, Sagar Dholariya, Anita Motiani, Ragini Singh. COVID-19-related liver injury: Focus on genetic and drug-induced perspectives. World Journal of Virology 2023; 12(1): 53-67 doi: 10.5501/wjv.v12.i1.53
Abstract(685) |
Core Tip(471) |
Full Article(HTML)(1538)
|
Full Article (PDF)-828K(149)
|
Full Article (Word)-253K(29)
|
Audio-744K(4)
|
Peer-Review Report-211K(63)
|
Answering Reviewers-102K(58)
|
Times Cited (0)
|
Total Visits (6383)
|
Open
|
| 49 |
Zeinab Nabil Ahmed Said, Safinaz Adel El Habashy, Samy Zaky, ESCMID Study Group for Viral Hepatitis. COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes. World Journal of Gastroenterology 2023; 29(7): 1123-1130 doi: 10.3748/wjg.v29.i7.1123
|